Jenny J. J.
Director of Policy @Novo Nordisk
Signup · Get unlimited contacts
WORK HISTORY
Director of Policy @Novo Nordisk
Washington, DC, US
Lead enterprise-wide U.S. health policy and reimbursement strategy, serving as a strategic advisor to senior leadership on how federal and state policy dynamics impact pricing, access, and long-term asset value.• Own and drive enterprise-level U.S. policy and reimbursement strategy across portfolio assets, aligning with evolving Medicare, Medicaid, and commercial payer landscapes• Anticipate and interpret complex policy developments (including IRA implementation, CMS rulemaking, and CMMI models), translating implications into actionable business and access strategies• Advise executive leadership (VP/SVP level) on policy-driven risks and opportunities impacting pricing, coverage, and commercialization decisions• Influence policy direction through direct engagement with CMS, Executive Branch agencies, and key stakeholder organizations across Medicare Parts A, B, and D• Lead cross-functional integration of policy insights across Market Access, Medical Affairs, Government Affairs, Legal, R&D, and Finance to inform enterprise strategy and lifecycle planning• Shape mitigation and scenario planning strategies to proactively address reimbursement and access risks across pipeline and inline products• Represent the organization in external policy forums, strengthening positioning on key access, reimbursement, and innovation issues• Mentor and develop team members, driving strategic thinking and elevating policy capabilities across the organization
EDUCATION
Penn State University
BS
University at Albany
MPH
ABOUT JENNY J. J.
Accomplished pharmaceutical and biopharmaceutical Director of Health Policy with 18+ years of leadership in U.S. reimbursement, market access, drug pricing, and public policy strategy.Expert in shaping federal and state healthcare policy, influencing CMS decision-making, and leading government affairs and advocacy initiatives that expand patient access and support sustainable growth. Proven track record of aligning cross-functional teams across market access, regulatory, medical affairs, and commercial organizations.Recognized leader in navigating complex healthcare and legislative environments, with deep expertise in:U.S. reimbursement policyDrug pricing and pricing reformMedicare & Medicaid policyMarket access strategyFederal and state advocacyTrade association engagementTrusted advisor to executive leadership and key external stakeholders, including CMS, Congress, and industry groups, with a reputation for anticipating regulatory shifts and translating policy into actionable business strategy.Passionate about advancing equitable access to innovative therapies through data-driven policy solutions and strategic partnerships.Employed by Novo Nordisk; views are my own.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.